
Tactile Systems (TCMD) Stock Forecast & Price Target
Tactile Systems (TCMD) Analyst Ratings
Bulls say
Tactile Systems Technology Inc. has demonstrated strong growth in its Afflovest product line, achieving $10.7 million in revenue for the quarter, representing a year-over-year increase of 22%, driven by fruitful partnerships with leading durable medical equipment (DME) providers. The company has also shown increased confidence in its DME partnerships by raising its growth guidance for fiscal year 2025 to 20-23%, a significant upgrade from the previous expectation of 6-9%. This positive outlook is further underscored by the need for effective home-based medical solutions, positioning Tactile Systems Technology favorably in the medical technology sector.
Bears say
Tactile Systems Technology Inc reported higher-than-expected operating expenses, resulting in an earnings per share (EPS) miss of -$0.13, significantly underperforming against estimates of -$0.05 to -$0.08. Additionally, the company has lowered its fiscal year 2025 revenue guidance to a range of $309 million to $315 million, which represents a $7 million decrease compared to previous projections, with growth expectations for its lymphedema business downgraded from 8-10% to 4-5%. Furthermore, the revised EBITDA expectations for FY 2025 are now between $32 million and $34 million, down from prior forecasts of $35 million to $37 million, indicating continued financial pressure.
This aggregate rating is based on analysts' research of Tactile Systems and is not a guaranteed prediction by Public.com or investment advice.
Tactile Systems (TCMD) Analyst Forecast & Price Prediction
Start investing in Tactile Systems (TCMD)
Order type
Buy in
Order amount
Est. shares
0 shares